FACTANKER · measured, cited, anchored official records connected

SEC EDGAR CompanyFacts fact · point in time

Orexigen Therapeutics, Inc.: cash_and_equivalents

One fact, its scope and the complete path back to the official record.

Period: as of 2014-03-31Status: currentProvenance attached

Cite: FACTANKER, https://factanker.com/fact/64e62772-be51-47d7-ad3e-b0a9e259f270

Reported value

$37.563M{"amount": 37563000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"}
Entity
Orexigen Therapeutics, Inc.
Metric
cash_and_equivalents
Period
as of 2014-03-31
Status
current
Source
SEC EDGAR CompanyFacts

Provenance

Official reference0001193125-14-192448 · Open the official SEC filing →
Source licenseUS-PD-17USC105
Retrieved2026-08-19T13:19:17.217275+02:00
Raw response SHA-256f7bde1a401b286c74a2fd824ee1df541…
Official-identifier pathhttps://factanker.com/fact/sec/cik-0001382911/cash-and-equivalents/2014-03-31 (CIK, metric, reporting date)
History
  • no predecessors — first report

Why this page exists

The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.